REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

Similar documents
2-Hypertrichosis:- Hypertrichosis is the

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Prof.Dr. Nabil Lymon Head of Internal Medicine Department


Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Hirsutism: Diagnosis and Treatment. Roger A. Lobo M.D. Columbia University

Polycystic Ovarian Syndrome (PCOS) LOGO

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

Polycystic Ovary Syndrome

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Polycystic Ovary Syndrome

Overview of Reproductive Endocrinology

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence

Amenorrhoea: polycystic ovary syndrome

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS):

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Abnormal Uterine Bleeding Case Studies

Polycystic Ovary Syndrome

Polycystic ovary syndrome

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome

Endocrine control of female reproductive function

PCOS and Obesity DUB is better treated by OCPs

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Hirsutism - Management

Clinical evaluation of hirsutism in South India

Polycystic Ovary Syndrome

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline

PCOS. Kirtly Parker Jones MD

Female Reproductive Endocrinology

GONADAL FUNCTION: An Overview

POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology

New PCOS guidelines: What s relevant to general practice

Syndrome in Clinical Practice

Polycystic Ovary Syndrome: Cardiovascular Disease risk

Androgen excess in the postmenopausal woman

REPRODUCTIVE ENDOCRINOLOGY

Polycystic Ovary Syndrome diagnosis & management

Metformin and Pioglitazone in Polycystic Ovarian Syndrome: A Comparative Study

INFERTILITY CAUSES. Basic evaluation of the female

International Journal of Pharma and Bio Sciences HIRSUTISM- A SYMPTOM RATHER THAN A DISEASE: A REVIEW

X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.

Polycystic Ovary Syndrome

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

A practical approach to the diagnosis of polycystic ovary syndrome

JMSCR Vol 05 Issue 04 Page April 2017

Bilan Hormonal. Question posée. Ovulation? Qualité de l ovulation? Vieillissement ovarien? Fonction thyroïdienne Fonction surrénalienne

Sexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist

JMSCR Vol 05 Issue 05 Page May 2017

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

AN AETIOLOGICAL STUDY OF MODERATE TO SEVERE HIRSUTISM

Polycystic Ovary Syndrome Therapy Dr. Pilar Vigil MD, PhD, FACOG

Vol-4 No.-2 July-September 2011

Risk Factors Contributing to Hirsutism

PCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University

Difference Between PCOS and Endometriosis

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

University of Cape Town

REPRODUCTIVE ENDOCRINOLOGY

DOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS

Addressing Practice Gaps in PCOS

UNDERSTANDING PCOS AND ITS DIAGNOSIS

EFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY. Department OB/GYN. EVMA Norfolk, Va Telephone: (804)

Abnormal Uterine Bleeding

Prevalence and hormonal profile of polycystic ovary syndrome in young Kashmiri women presenting with hirsutism: A hospital based study

PCOS guidelines: What s relevant to general practice

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies

3 year old boy with puberty. Katie Stanley, MD August 1, 2013

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

Female androgen profiles by MS for PCOS patients. CS Ho APCCMS 2010, Hong Kong 14 January 2010

Clinical Profile Polycystic Ovarian Syndrome Cases

Gynecological Problems: Case Study Approach

Reproductive FSH. Analyte Information

Test Briefing on Hormonal Disorders and Infertility

Diagnosis and Management of PCOS

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

The Impact of Insulin Resistance on Long-Term Health in PCOS

ENDOCRINOLOGY. Victoria Ruszala North Bristol NHS Trust. September 2017

About PCOS. About PCOS

Reproductive Health and Pituitary Disease

Transcription:

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

CASE #1 46 year old female presents with complaint of increased facial and abdominal hair growth for 6-8 months. She has had increased acne. Her hair stylist noted to her that she is having hair thinning at the crown. She has history of slightly irregular menstrual cycles but only 2 in the last 8 months.

WHAT S THE DIFFERE NTIAL DIAGNO SIS?

DIFF DX: HIRSUTISM PCOS (75-80%) Ovarian tumors (SertoliLeydig, stromal cell) - (0.2%) Adrenal tumors Stromal hyperthecosis (severe insulin resistance & mostly post-menopausal) Late-onset 21-hydroxylase deficiency Drugs (androgens, androgenic progestins) Idiopathic Luteoma of pregnancy/ hyperreactio luteinalis

PRINCIPAL CAUSES OF HIRSUTISM Increase in circulating androgens Ovarian, adrenal, or exogenous Increase in target hair follicle sensitivity Due to excess 5α- reductase activity Normal androgen levels

MAIN CONDITIONS OF EXCESS HAIR GROWTH Hirsutism: male pattern, affects 5-10% Virilization: androgenic state hirsutism, deepening of the voice, breast atrophy, increased muscle bulk, clitoromegaly, increased libido, acne, and male-pattern balding (androgenic alopecia) Hypertrichosis: diffusely increased total body hair drugs such as phenytoic, minoxidil, cyclosporine hypothyroidism, anorexia, malnutrition

HISTOR Y SHOUL D YOU OBTAIN?

FURTHER HISTORY Other symptoms: Hair loss Voice deepening Endocrine ROS Family history menstrual, reproductive, endocrine, cancers Medications: Danazol, valproate, antipsychotics, androgens

IMPORTANT HISTORICAL Timing of onset of symptoms CONTEXT Menstrual history Tempo of progression of symptoms Severity of symptoms

L FINDING S WOULD YOU BE LOOKING FOR?

PHYSICAL EXAMINATION Hair Pattern/Distribution Ferriman-Gallwey Acne Mediterranean, hispanic, middle eastern > 9-10 AA/C - >8 Asian > 2 Male pattern hair loss Virilization Clitoromegaly (L > 10mm, LxW > 35mm2) Voice deepening Increased muscle mass Temporal / Crown balding

SPECIAL CONSIDERATION Acanthosis nigricans S Striae Easy bruising

TEST WOULD YOU LIKE TO ORDER?

YOUR INITIAL TEST RESULT WAS: TESTOSTERONE - 150 NG/DL YOU ALSO ORDERED A: DHEAS - 720 MCG/DL Further evaluation at this point?

TRANSVAGINAL ULTRASOUND Result : Normal

SUSPICIOUS FINDINGS large cysts (> 8 cm) solid masses complex cysts which do not resolve in 2-4 wks **hilus cell / sex cord stream tumors may not be visible on US or even at surgery Sertoli-Leydig ave. 16cm at dx 2nd/3rd decade nearly completely solid without polycystic appearance and increased storm - hyperthecosis

CT - ADRENAL GLANDS Results: left adrenal mass - 6 cm

HOW DO YOU TREAT HER HIRSUTI SM?

COMMON METHODS FOR HAIR REMOVAL Permanent: Electrolysis Laser Eflornithine hydrochloride (Vaniqua) improves outcomes Temporary: Depilatory Shaving Waxing/Bleaching Prevention for those w/ chronic hyperandrogenism OCPs Spironolactone (antiandrogens) Finasteride (limited data) - $$$

CASE #2

CASE #2 18 year old female with menses q 1-2 months for 3 years and none x 4 months + hirsutism + acne - utilizes topical antibiotics with some benefit BMI = 46 Reports fatigue is affecting her grades in college What is the most likely diagnosis?

WHAT TESTIN G WOULD YOU DO?

IRREGULAR MENSES, hcg HIRSUTISM Testosterone Prolactin TSH 17OHP FSH/E2

CONFIRMED PCOS OR OTHER RISK FACTORS A1c or 2h GTT Fasting lipid profile Screen for cardiometabolic risk factors

HOW DO YOU DIAGNOS E PCOS?

ROTTERDAM CRITERIA Need 2 of 3 Hyperandrogenism or hyperandrogenemia Oligo or amenorrhea Polycystic appearance on US FNPO > 12, volume > 10cm 3

PATHOGENESIS: FUNCTIONAL OVARIAN HYPERANDROGENISM Complex genetic trait multiple genetic variants and environmental factors interact twin studies: monozygotic correlation 71%, dizygotic 38% 20-40% prevalence in mothers/sisters Ovarian hyperinsulinemia: upregulate androgen production in response to LH and stimulates adipogenesis. Incr androgens causes secondary LH elevation and interferes w/ negative feedback. LH aggravates ovarian dysfunction.

GENE ALTERATIONS Genes regulating gonadotropin secretion/action, insulin secretion/action, weight/energy regulation; androgen biosynthesis/action Altered LH action (incr pulse frequency/amplitude); LH receptor overexpression in granulosa cells Granulosa cells prematurely luteinize: overexposed LH receptor, secrete E2 due to LH inappropriately early; hyper-responsive to FSH and overproduce E2 Androgen excess from theca cells (enhanced by granulosa dysfunction) promotes small follicles (increased responsiveness) Oocyte gene expression dysregulated. Reduced developmental capacity of oocytes : excessive androgens and epigenetic metabolic signals

LONG-TERM HEALTH CONSIDERA TIONS SHOULD YOU ADVISE HER ABOUT?

4 AREAS OF CONCERN Infertility Diabetes/Gestational DM/Insulin resistance Dyslipidemia Uterine hyperplasia/endometrial cancer

IN PREMENOPAUSAL WOMEN, THE MENSTRUAL CYCLE IS A VITAL SIGN!